Literature DB >> 30217676

FGF23 beyond Phosphotropic Hormone.

Yuichi Takashi1, Seiji Fukumoto2.   

Abstract

Fibroblast growth factor (FGF) 23 is a bone-derived phosphotropic hormone that regulates phosphate and vitamin D metabolism. FGF23 mainly affects kidney function via the FGF receptor (FGFR)/α-Klotho complex. The physiological roles of FGF23 and α-Klotho in the regulation of mineral homeostasis have been well established. In addition, recent studies have reported that FGF23 has various effects on many other tissues, sometimes in an α-Klotho-independent manner, especially under pathological conditions. However, how FGF23 works in these tissues without α-Klotho is not entirely clear. Here we review the recent reports concerning the actions of FGF23 on various tissues and discuss the remaining questions about FGF23.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; fibroblast growth factor 23; fibroblast growth factor receptor; phosphate; α-Klotho

Mesh:

Substances:

Year:  2018        PMID: 30217676     DOI: 10.1016/j.tem.2018.08.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  19 in total

1.  Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.

Authors:  Yuichi Takashi; Shu Wakino; Hitoshi Minakuchi; Masashi Ishizu; Akio Kuroda; Hisato Shima; Manabu Tashiro; Keiko Miya; Kazuyoshi Okada; Jun Minakuchi; Shu Kawashima; Munehide Matsuhisa; Toshio Matsumoto; Seiji Fukumoto
Journal:  J Bone Miner Metab       Date:  2019-08-16       Impact factor: 2.626

2.  Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients.

Authors:  Shaohui Gao; Jinsheng Xu; Shenglei Zhang; Jingjing Jin
Journal:  Blood Purif       Date:  2019-01-30       Impact factor: 2.614

3.  Phosphate-Sensing.

Authors:  Yuichi Takashi; Seiji Fukumoto
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  The role of RANKL and FGF23 in Assessing Bone Turnover in Type 2 Diabetic Patients.

Authors:  G Niță; O Niță; A Gherasim; L I Arhire; A M Herghelegiu; L Mihalache; C Tuchilus; M Graur
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 1.104

5.  Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.

Authors:  Rebecca Frazier; Alexander Hodakowski; Xuan Cai; Jungwha Lee; Anaadriana Zakarija; Brady Stein; Valentin David; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal:  Bone       Date:  2020-07-28       Impact factor: 4.398

Review 6.  Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins.

Authors:  Marta Latko; Aleksandra Czyrek; Natalia Porębska; Marika Kucińska; Jacek Otlewski; Małgorzata Zakrzewska; Łukasz Opaliński
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

Review 7.  Bone function, dysfunction and its role in diseases including critical illness.

Authors:  Nan Su; Jing Yang; Yangli Xie; Xiaolan Du; Hangang Chen; Hong Zhou; Lin Chen
Journal:  Int J Biol Sci       Date:  2019-01-29       Impact factor: 6.580

8.  Transgenic mouse model for conditional expression of influenza hemagglutinin-tagged human SLC20A1/PIT1.

Authors:  Sampada Chande; Bryan Ho; Jonathan Fetene; Clemens Bergwitz
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

9.  Phenotypes of Klotho.

Authors:  Jyoti Misra Sen
Journal:  Aging (Albany NY)       Date:  2019-07-20       Impact factor: 5.682

10.  Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial.

Authors:  Xiang-Yang Liu; Jing-Rui Yao; Rong Xu; Lin-Xin Xu; Yue-Feng Zhang; Shan Lu; Zhi-Heng Xing; Li-Ping Fan; Zhong-Hua Qin; Bei Sun
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.